- Report
- July 2024
- 100 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- October 2024
- 191 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- October 2024
- 183 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 182 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- December 2024
- 150 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- July 2024
- 150 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- July 2024
- 158 Pages
Global
From €4028EUR$4,250USD£3,365GBP
- Report
- December 2024
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- February 2025
- 61 Pages
North America
From €5682EUR$5,995USD£4,747GBP
- Report
- February 2025
- 84 Pages
Europe
From €5682EUR$5,995USD£4,747GBP
- Report
- February 2025
- 81 Pages
Asia Pacific
From €5682EUR$5,995USD£4,747GBP
- Report
- January 2024
- 459 Pages
Global
From €6777EUR$7,150USD£5,662GBP
- Report
- September 2023
- 188 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- November 2023
- 250 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- October 2023
- 189 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- April 2023
- 85 Pages
United States
From €4502EUR$4,750USD£3,761GBP
- Report
- April 2023
- 71 Pages
Italy
From €4502EUR$4,750USD£3,761GBP
- Report
- April 2023
- 85 Pages
Australia
From €4502EUR$4,750USD£3,761GBP
- Report
- April 2023
- 69 Pages
India
From €4502EUR$4,750USD£3,761GBP

Within the optical healthcare field, the market for glaucoma drainage devices encompasses a variety of medical apparatus designed to alleviate intraocular pressure (IOP) in patients suffering from glaucoma. These devices consist of microscopic shunts or valves that facilitate the drainage of aqueous humor, the fluid inside the eye whose improper regulation can lead to the increased pressure responsible for glaucoma. The treatment aims to prevent further optic nerve damage and preserve the patient's vision.
The necessity for such drainage devices arises in cases where conventional therapies, such as medications or laser treatments, fail to adequately control IOP. Glaucoma drainage devices are often considered when the disease progresses to a more advanced stage or when patients exhibit a resistance to first-line treatment options. Ophthalmologists and eye surgeons employ these devices, tailoring their use to match the patient's specific type of glauocolma and the severity of their case. Technological advancements continuously influence the development of these devices, focusing on improving biocompatibility, reducing post-operative complications, and enhancing long-term efficacy.
Among the companies specializing in the glaucoma drainage devices market are Allergan, PLC, implanted with their well-known brand—Ahmed Glaucoma Valve; New World Medical, which produces the Baerveldt Glaucoma Implant; Glaukos Corporation, known for their iStent technology; and Mölnlycke Health Care, which markets several drainage implants designed for use in various glaucoma surgeries. These companies are integral Show Less Read more